FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for alogliptin from Padagis Israel Pharmaceuticals Ltd, indicating an update related to the product's approved use or la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)

Snippet

SUPPL AP for ALOGLIPTIN (ALOGLIPTIN)